Heron Therapeutics (HRTX) Stock Price & Financial Analysis
Heron Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Heron Therapeutics
What is the current stock price for HRTX?
As of the latest trading session, HRTX stock trades at $0.46. The 52-week range is $0.38–$1.97, with a day range of $0.45–$0.48.
What is the P/E ratio for HRTX?
The P/E ratio (Price-to-Earnings) for HRTX is shown in the Key Statistics section. This valuation metric helps compare Heron Therapeutics, Inc. to industry peers.
Does HRTX pay dividends?
Heron Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for HRTX?
Analyst ratings and recommendations for HRTX are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of HRTX?
Heron Therapeutics's market capitalization is $87.0M, classifying it as a micro-cap company. Heron Therapeutics operates in the Healthcare sector within the Biotechnology industry.